SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028575
Filing Date
2021-11-15
Accepted
2021-11-15 16:06:18
Documents
80
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 912440
2 ex31-1.htm EX-31.1 14524
3 ex31-2.htm EX-31.2 14820
4 ex32.htm EX-32 10969
  Complete submission text file 0001493152-21-028575.txt   5725801

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE invo-20210930.xsd EX-101.SCH 58746
6 XBRL CALCULATION FILE invo-20210930_cal.xml EX-101.CAL 69646
7 XBRL DEFINITION FILE invo-20210930_def.xml EX-101.DEF 228228
8 XBRL LABEL FILE invo-20210930_lab.xml EX-101.LAB 465172
9 XBRL PRESENTATION FILE invo-20210930_pre.xml EX-101.PRE 361070
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 746207
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39701 | Film No.: 211410386
SIC: 3841 Surgical & Medical Instruments & Apparatus